Peer-reviewedLicence not statedActa Pharmacologica Sinica
Targeted protein degradation: bridging chemical biology and clinical translation
- 1Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Innovation Institute for Artificial Intelligence in Medicine of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058 China
- 2School of Medicine, Hangzhou City University, Hangzhou, 310015 China
Related
- Targeted protein degradation in cancer: strategies for undruggable targets and progress towards clinical translation.
- Nanomaterial-enabled RNA therapeutics: bridging delivery barriers to clinical translation
- USP9X promotes the degradation of trapped translation factors on collided ribosomes
- Targeted degradation of a constitutively active GPCR oncoprotein
- Bridging MS2 Spectra and Chemical Space: Advances in Spectral Similarity, Molecular Retrieval, and De Novo Structure Discovery
BibTeX
@article{zhang2026targeted,
title = {{Targeted protein degradation: bridging chemical biology and clinical translation}},
author = {Yu-bo Zhang and Jun-wei Fu and Yue Liu and Rui-lin Wu and Yan-ting Liang and Wen-han Zhang and Tao Yuan and Hong Zhu and Qiao-jun He and Bo Yang},
journal = {Acta Pharmacologica Sinica},
year = {2026},
month = jul,
doi = {10.1038/s41401-026-01861-2},
url = {https://doi.org/10.1038/s41401-026-01861-2},
}
RIS
TY - JOUR
TI - Targeted protein degradation: bridging chemical biology and clinical translation
AU - Yu-bo Zhang
AU - Jun-wei Fu
AU - Yue Liu
AU - Rui-lin Wu
AU - Yan-ting Liang
AU - Wen-han Zhang
AU - Tao Yuan
AU - Hong Zhu
AU - Qiao-jun He
AU - Bo Yang
PY - 2026
DA - 2026/07/07
JO - Acta Pharmacologica Sinica
DO - 10.1038/s41401-026-01861-2
UR - https://doi.org/10.1038/s41401-026-01861-2
SN - 1671-4083
SN - 1745-7254
ER -